Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/34336
Title: Computational strategies to combat COVID-19: useful tools to accelerate SARS-CoV-2 and coronavirus research
Authors: Hufsky, Franziska
Lamkiewicz, Kevin
Almeida, Alexandre
Aouacheria, Abdel
Arighi, Cecilia
Bateman, Alex
Baumbach, Jan
Beerenwinkel, Niko
Brandt, Christian
Cacciabue, Marco
Chuguransky, Sara
Drechsel, Oliver
Finn, Robert D
Fritz, Adrian
Fuchs, Stephan
Hattab, Georges
Hauschild, Anne-Christin
Heider, Dominik
Hoffmann, Marie
Hölzer, Martin
Hoops, Stefan
Kaderali, Lars
Kalvari, Ioanna
von Kleist, Max
Kmiecinski, Renó
Kühnert, Denise
Lasso, Gorka
LIBIN, Pieter 
List, Markus
Löchel, Hannah F
Martin, Maria J
Martin, Roman
Matschinske, Julian
McHardy, Alice C
Mendes, Pedro
Mistry, Jaina
Navratil, Vincent
Nawrocki, Eric P
O'Toole, Áine Niamh
Ontiveros-Palacios, Nancy
Petrov, Anton I
Rangel-Pineros, Guillermo
Redaschi, Nicole
Reimering, Susanne
Reinert, Knut
Reyes, Alejandro
Richardson, Lorna
Robertson, David L
Sadegh, Sepideh
Singer, Joshua B
Theys, Kristof
Upton, Chris
Welzel, Marius
Williams, Lowri
Marz, Manja
Issue Date: 2021
Publisher: OXFORD UNIV PRESS
Source: BRIEFINGS IN BIOINFORMATICS, 22 (2) , p. 642 -663
Abstract: SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) is a novel virus of the family Coronaviridae. The virus causes the infectious disease COVID-19. The biology of coronaviruses has been studied for many years. However, bioinformatics tools designed explicitly for SARS-CoV-2 have only recently been developed as a rapid reaction to the need for fast detection, understanding and treatment of COVID-19. To control the ongoing COVID-19 pandemic, it is of utmost importance to get insight into the evolution and pathogenesis of the virus. In this review, we cover bioinformatics workflows and tools for the routine detection of SARS-CoV-2 infection, the reliable analysis of sequencing data, the tracking of the COVID-19 pandemic and evaluation of containment measures, the study of coronavirus evolution, the discovery of potential drug targets and development of therapeutic strategies. For each tool, we briefly describe its use case and how it advances research specifically for SARS-CoV-2. All tools are free to use and available online, either through web applications or public code repositories. Contact:evbc@unj-jena.de.
Keywords: SARS-CoV-2;drug design;epidemiology;sequencing;tools;virus bioinformatics;Biomedical Research;COVID-19;Genome, Viral;Humans;Pandemics;SARS-CoV-2;Computational Biology
Document URI: http://hdl.handle.net/1942/34336
ISSN: 1467-5463
e-ISSN: 1477-4054
DOI: 10.1093/bib/bbaa232
ISI #: WOS:000642298000004
Rights: © The Author(s) 2020. Published by Oxford University Press. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
Category: A1
Type: Journal Contribution
Validations: ecoom 2022
Appears in Collections:Research publications

Files in This Item:
File Description SizeFormat 
bbaa232.pdfPublished version2.36 MBAdobe PDFView/Open
Show full item record

WEB OF SCIENCETM
Citations

72
checked on Apr 30, 2024

Page view(s)

50
checked on Aug 9, 2022

Download(s)

32
checked on Aug 9, 2022

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.